Issue

Learning Objectives
After reading this supplement, participants should be better able to:

• Identify the etiologies of OAB in geriatric patients
• Describe the potential cognitive and cardiac side effects of anticholinergic therapy
• Evaluate the current drug treatments for OAB with regard to safety and efficacy in geriatric patients

This educational activity is sponsored by the American Geriatrics Society.

This activity is supported by an educational grant from Novartis Pharmaceuticals.

Needs Statement
The single fastest-growing segment of the population is that ov